Syndeio Biosciences, Inc
Clinical trials sponsored by Syndeio Biosciences, Inc, explained in plain language.
-
Weekly pill tested as new hope for depression
Disease control Recruiting nowThis study is testing whether a weekly oral medication called GATE-251 can safely reduce symptoms of major depression in adults. Participants will take either the study drug or a placebo (inactive pill) once a week for six weeks and visit a clinic weekly for depression assessment…
Phase: PHASE2 • Sponsor: Syndeio Biosciences, Inc • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Weekly pill trial aims to ease depression
Symptom relief Recruiting nowThis study is testing whether a weekly oral medication called GATE-251 (zelquistinel) can safely reduce symptoms of major depression in adults. About 164 participants will be randomly assigned to take either the study drug or a placebo pill once a week for six weeks. Researchers …
Phase: PHASE2 • Sponsor: Syndeio Biosciences, Inc • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC